Item 3.03. Material Modification to Rights of Security Holders.
On February 11, 2020, InVivo Therapeutics Holdings Corp. (the "Company")
effected a reverse stock split of the Company's common stock, par value $0.00001
per share (the "Common Stock"), at a ratio of 1-for-30 (the "Reverse Split"). As
a result of the Reverse Split, every 30 shares of the issued and outstanding
Common Stock were automatically converted into one newly issued and outstanding
share of Common Stock, without any change in the par value per share. Any
fractional shares resulting from the Reverse Split have been rounded up to the
nearest whole share. In connection with the Reverse Split, the Company
correspondingly reduced the number of shares of authorized shares of Common
Stock from 500,000,000 to 16,666,667.
As previously disclosed, the Board of Directors of the Company approved the
Reverse Split on February 3, 2020. On February 10, 2020, the Company filed a
Certificate of Change to effect the Reverse Split pursuant to Nevada Revised
Statutes Sections 78.207 and 78.209 with the Secretary of State of the State of
Nevada. Under Nevada law, the Company's Articles of Incorporation were deemed
amended at the effective time of the Reverse Split, 5:00 p.m. Eastern Time on
February 11, 2020.
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in
Fiscal Year.
The information set forth in Item 3.03 of this Current Report on Form 8-K is
incorporated by reference into this Item 5.03. A copy of the Certificate of
Change is filed as Exhibit 3.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
3.1 Certificate of Change Pursuant to NRS 78.209, filed with the Nevada
Secretary of State, dated February 10, 2020.
© Edgar Online, source Glimpses